An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease
Calhoun A, King C, Khoury R, Grossberg GT. An evaluation of memantine ER + donepezil for the treatment of Alzheimer’s disease. Expert Opinion On Pharmacotherapy 2018, 19: 1711-1717. PMID: 30244611, DOI: 10.1080/14656566.2018.1519022.Peer-Reviewed Original ResearchConceptsAlzheimer's diseaseNMDA receptor antagonist memantineSafety/tolerability dataDisease-modifying treatmentsSevere Alzheimer's diseaseCommon neurodegenerative diseaseMemantine ERTolerability dataTreatment regimenMedication adherenceCombination therapyPoor adherenceCaregiver burdenSocietal burdenDose combinationWarrants further considerationDrug AdministrationCaregiver supportCholinesterase inhibitorsPatientsDonepezilLiterature searchMemantineDiseaseNeurodegenerative diseases
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply